STOCK TITAN

Biolife Solutions Inc - BLFS STOCK NEWS

Welcome to our dedicated news page for Biolife Solutions (Ticker: BLFS), a resource for investors and traders seeking the latest updates and insights on Biolife Solutions.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Biolife Solutions's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Biolife Solutions's position in the market.

Rhea-AI Summary
BioLife Solutions, Inc. (NASDAQ: BLFS) has announced the divestiture of its subsidiary Global Cooling, Inc. (
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
-
Rhea-AI Summary
BioLife Solutions, Inc. (BLFS) announces CEO and CFO to present at March Investor Conferences. The company will participate in TD Cowen 44th Annual Healthcare Conference and Key Banc Virtual Conference, engaging with investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
-
Rhea-AI Summary
BioLife Solutions, Inc. (BLFS) reports a 11% sequential increase in Cell Processing revenue to $14.8 million in Q4 2023, with a positive adjusted EBITDA of $700,000. The company expects 2024 revenue of $95.5 - $100.0 million, excluding the freezer business. The strategic focus on high-margin consumable offerings and divestiture of low-margin freezer franchise aims to enhance shareholder value and financial profile.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.33%
Tags
Rhea-AI Summary
BioLife Solutions, Inc. (NASDAQ: BLFS) announced the release of its fourth-quarter and full-year 2023 financial results on February 29, 2024. The Company will conduct a conference call and webcast to discuss the financial results and provide a business update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
conferences earnings
-
Rhea-AI Summary
BioLife Solutions, Inc. (BLFS) reported a fourth-quarter cell processing revenue increase of 11% sequentially to $14.8 million. However, the company's full-year 2023 preliminary unaudited revenue decreased by 11% to $143.3 million compared to 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.16%
Tags
none
-
Rhea-AI Summary
BioLife Solutions, Inc. (Nasdaq: BLFS) announced Q3 2023 financial results, reporting $33.3 million in revenue, a decrease of 18% from Q3 2022, with strong ex-COVID growth of 50% in biostorage services. The company expects full year 2023 revenue to be at the low end of the guidance range, reflecting a year-over-year decrease of 11%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.86%
Tags
Rhea-AI Summary
BioLife Solutions, Inc. (NASDAQ: BLFS) will release its third quarter financial results on November 9, 2023, after market close. The company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) to discuss the results and provide a general business update. The webcast can be accessed on the Investor Relations page of the BioLife Solutions website, and the conference call can be dialed in at (800) 715-9871 with the conference ID number 5946398. A webcast replay will be available on the company's website for 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
-
Rhea-AI Summary
BioLife Solutions appoints Roderick de Greef as Chairman and CEO, and Garrie Richardson as Chief Revenue Officer. Preliminary Q3 revenue is $33.3 million, with full year 2023 revenue expected at the low end of the guidance range. De Greef aims to focus on cell processing and biostorage platforms, divest freezer product lines, and restore revenue growth and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
Biolife Solutions Inc

Nasdaq:BLFS

BLFS Rankings

BLFS Stock Data

724.80M
32.61M
3.56%
102.15%
7.06%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Bothell

About BLFS

bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.